Table 4 Joinpoint analysis of trends in the premature mortality of four major NCDs in Nanjing (2007–2018)
From: ‘Trend in premature mortality from four major NCDs in Nanjing, China, 2007–2018’
Total Study Period | Trend 1 | Trend 2 | Trend 3 | ||||
|---|---|---|---|---|---|---|---|
AAPC (%, 95 CI) | years | APC (%) | years | APC (%) | years | APC (%) | |
All | − 4.3*(− 5.3 ~ − 3.4) | 2007–2010 | 0.1 | 2010–2013 | −11.9* | 2013–2018 | − 2.2* |
Subcategory | |||||||
Cancers | −4.2*(− 5.9 ~ − 2.5) | 2007–2010 | − 0.2 | 2010–2013 | − 11.8* | 2013–2018 | −1.7 |
Diabetes | −1.6(− 6.7 ~ 3.8) | 2007–2009 | 6.3 | 2009–2013 | − 12.4 | 2013–2018 | 4.7 |
Cardiovascular disease | − 5.0*(− 6.9 ~ − 3.2) | 2007–2010 | 0.1 | 2010–2014 | −11.4* | 2014–2018 | −2.2 |
Chronic respiratory diseases | −5.9*(− 6.9 ~ − 4.8) | 2007–2018 | |||||
Gender | |||||||
Male | − 4.2*(− 6.0 ~ −2.5) | 2007–2010 | 0.2 | 2010–2013 | − 12.5* | 2013–2018 | − 1.4 |
Female | −4.6*(− 6.4 ~ − 2.7) | 2007–2010 | 0.7 | 2010–2013 | − 11.4* | 2013–2018 | − 3.4* |
Geographic | |||||||
Urban | −3.3*(−5.4 ~ −1.1) | 2007–2010 | − 0.5 | 2010–2013 | −9.9* | 2013–2018 | −0.7 |
Rural | − 5.2*(− 6.8 ~ − 3.4) | 2007–2010 | 0.2 | 2010–2013 | − 12.9* | 2013–2018 | − 3.4* |